000 01483 a2200421 4500
005 20250515075001.0
264 0 _c20071022
008 200710s 0 0 eng d
022 _a1607-8454
024 7 _a10.1080/10245330701283959
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRichard, Vijay Samuel
245 0 0 _aShould we test TPMT enzyme levels before starting azathioprine?
_h[electronic resource]
260 _bHematology (Amsterdam, Netherlands)
_cAug 2007
300 _a359-60 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAged
650 0 4 _aArthritis, Rheumatoid
_xdrug therapy
650 0 4 _aAzathioprine
_xadverse effects
650 0 4 _aBone Marrow Diseases
_xchemically induced
650 0 4 _aDiagnostic Tests, Routine
_xeconomics
650 0 4 _aFemale
650 0 4 _aHomozygote
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xadverse effects
650 0 4 _aInactivation, Metabolic
650 0 4 _aMercaptopurine
_xpharmacokinetics
650 0 4 _aMethylation
650 0 4 _aMethyltransferases
_xblood
650 0 4 _aNeutropenia
_xchemically induced
650 0 4 _aProdrugs
_xadverse effects
650 0 4 _aSepsis
_xetiology
650 0 4 _aUnited Kingdom
700 1 _aAl-Ismail, Deana
700 1 _aSalamat, Ahmed
773 0 _tHematology (Amsterdam, Netherlands)
_gvol. 12
_gno. 4
_gp. 359-60
856 4 0 _uhttps://doi.org/10.1080/10245330701283959
_zAvailable from publisher's website
999 _c17187845
_d17187845